ArticleCancer & metabolism2026

CRISPR screen identifies autophagy inhibition (GNS561) as a PARP inhibitor (AZD5305) combination strategy in small cell lung cancer.

Tony Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.